SCHEMBL19013294

SCHEMBL19013294

CCCC(CCC)c1ccccc1CC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 3/20 0.47
CYSLTR1 Q9Y271 3/20 0.47
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
GABRA1 P14867 2/20 0.38
GABRB2 P47870 2/20 0.38
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MGLL Q99685 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KCNH2 Q12809 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11128160 0.92 CYSLTR2 (0.54) CYSLTR2CYSLTR1TAS1R3TAS1R1CYP3A4
SCHEMBL9276125 0.82 GABRA1 (0.41) CYSLTR2CYSLTR1GABRA1GABRB2MAPT
SCHEMBL18242291 0.81 GABRA1 (0.41) CYSLTR2CYSLTR1TAS1R3TAS1R1GABRA1
SCHEMBL9722014 0.81 TSHR (0.41) CYSLTR2CYSLTR1TAS1R3TAS1R1GABRA1
SCHEMBL6055228 0.79 TAS1R3 (0.42) CYSLTR2CYSLTR1TAS1R3TAS1R1GABRA1
SCHEMBL14527948 0.79 TAS1R3 (0.39) CYSLTR2CYSLTR1TAS1R3TAS1R1GABRA1
SCHEMBL16534648 0.79 TAS1R3 (0.42) CYSLTR2CYSLTR1TAS1R3TAS1R1GABRA1
SCHEMBL11075360 0.78 GABBR2 (0.38) CYSLTR2CYSLTR1GABRA1GABRB2MAPT
SCHEMBL21175585 0.78 TAS1R3 (0.38) CYSLTR2CYSLTR1TAS1R3TAS1R1GABRA1
SCHEMBL1828572 0.76 TAS1R3 (0.37) CYSLTR2CYSLTR1TAS1R3TAS1R1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017103888-A1 INDANE DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS NOVARTIS AG (CH) 2017-06-22 WO disclosed